Instrument Inactif

Communiqués CELSION NYSE

Actions

CLN

US15117N3052

Cours en clôture NYSE
- ^USD	-

Communiqués

30/11/-1	Celsion Corp : Celsion Retains Cameron Associates as Investor Relations Advisor	BU
30/11/-1	Celsion Corp : Celsion Announces Acceleration Plans for Its Breast Cancer Phase I Study	BU
30/11/-1	Celsion Corp : Celsion Corporation Updates Second Quarter 2007 Financial Results	BU
30/11/-1	Celsion Corp : Celsion Corporation Reports Second Quarter 2007 Financial Results	BU
30/11/-1	Celsion Corp : Celsion To Hold Second Quarter Earnings Call Friday, August 10, 2007	BU
30/11/-1	Celsion Corp : Celsion Reports Positive Meetings with the FDA	BU
30/11/-1	Celsion Corp : Celsion Announces AMEX Listing Compliance	BU
30/11/-1	Celsion Corp : Celsion Reports Early Success with Second Drug	BU
30/11/-1	Celsion Corp : Celsion Completes Sale of Prolieve Assets	BU
30/11/-1	Celsion Corp : Celsion Announces Results of 2007 Annual Stockholder Meeting	BU
30/11/-1	Celsion Corp : Celsion to Hold Annual Meeting: Shareholders May Participate by Telephone or Webcast	BU
30/11/-1	Celsion Corp : Celsion Completes Enrollment in Phase I Liver Cancer Study	BU
30/11/-1	Celsion Corp : Clinical Activity for Celsion's ThermoDox(R) Reported in Newly Presented Data	BU
30/11/-1	Celsion Corp : Celsion Corporation Reports First Quarter 2007 Results	BU
30/11/-1	Celsion Corp : Celsion to Hold First Quarter Earnings Call Friday, May 11, 2007	BU
30/11/-1	Celsion Corp : Celsion to Hold a Conference Call on Friday, April 20, 2007 to Discuss Proposed Sale of Prolieve(R) Assets and Other Proposals for 2007 Annual Meeting of Stockholders	BU
30/11/-1	Celsion Corp : Celsion Announces Boston Scientific Exercises Its Option to Purchase Prolieve(R) Assets	BU
30/11/-1	Celsion Corp : Celsion Obtains from Valentis Exclusive Rights to Pegylation Patents for use with Heat Activated Liposomes	BU
30/11/-1	Celsion Corp : ThermoDox(TM) Animal Studies to be Presented at 6th International Symposium on Therapeutic Ultrasound in Oxford, England	BU
30/11/-1	Celsion Corp : Celsion Corporation Resumes Shipment of Prolieve Thermodilatation(R) Catheter Kits	BU
30/11/-1	Celsion Corp : Celsion Corporation Reports Second Quarter 2006 Financial Results	BU
30/11/-1	Celsion Corp : American Stock Exchange Accepts Celsion Corporation's Plan of Compliance and Notifies Company of Noncompliance with Further Listing Standards	BU
30/11/-1	Celsion Corp : Celsion Corporation Successful in Having American Medical Systems, Inc. Patent Infringement Suit Dismissed in Minnesota	BU
30/11/-1	Celsion Corp : Celsion Files for Special Protocol Assessment for ThermoDox in combination with Radiofrequency Ablation for treatment of Non-Resectable Hepatocellular Carcinoma	BU
30/11/-1	Celsion Corp : Celsion Expands Board, Appoints New Independent Director	BU